Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach-Reference-Cited by-同舟云学术

Perspectives on Chronic Kidney Disease With Type 2 Diabetes and Risk Management: Practical Viewpoints and a Paradigm Shift Using a Pillar Approach

Published:2023-06-02 Issue:4 Volume:41 Page:553-566
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Morales Javier¹^ORCID,Dagogo-Jack Sam²^ORCID,Fonseca Vivian³,Neumiller Joshua J.⁴,Rosas Sylvia E.⁵

Affiliation:

1. 1Advanced Internal Medicine P.C., Greenvale, NY

2. 2Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN

3. 3Department of Medicine and Pharmacology, School of Medicine, Tulane University, New Orleans, LA

4. 4Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Pullman, WA

5. 5Joslin Diabetes Center and Harvard Medical School, Boston, MA

Funder

Bayer Corporation

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/41/4/553/735428/diaclincd220110.pdf

Reference65 articles.

1. American Diabetes Association . Living standards update. Available from https://professional.diabetes.org/content-page/living-standards-update. Accessed 26 September 2022

2. Introduction: Standards of Medical Care in Diabetes—2022;American Diabetes Association;Diabetes Care,2022

3. 11. Chronic kidney disease and risk management: Standards of Medical Care in Diabetes—2022;American Diabetes Association Professional Practice Committee;Diabetes Care,2022

4. 11. Chronic kidney disease and risk management: Standards of Care in Diabetes—2023;ElSayed;Diabetes Care,2023

5. 11. Microvascular complications and foot care: Standards of Medical Care in Diabetes—2021;American Diabetes Association;Diabetes Care,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes;BMC Nephrology;2024-08-01

2. Tonabersat suppresses priming/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease;Cell Communication and Signaling;2024-07-05

3. Chronic Kidney Disease and SGLT2 Inhibitors;The Journal of Korean Diabetes;2024-03-31